Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration

Ther Drug Monit. 2001 Oct;23(5):587-8. doi: 10.1097/00007691-200110000-00013.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacokinetics
  • Cilastatin / pharmacology
  • Cilastatin, Imipenem Drug Combination
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Drug Monitoring*
  • Hemofiltration*
  • Humans
  • Imipenem / pharmacology
  • Kidney Transplantation*
  • Male
  • Multiple Organ Failure / complications
  • Sepsis / complications
  • Serum Albumin / deficiency*
  • Teicoplanin / administration & dosage*
  • Teicoplanin / blood
  • Teicoplanin / pharmacokinetics

Substances

  • Anti-Bacterial Agents
  • Drug Combinations
  • Serum Albumin
  • Cilastatin
  • Teicoplanin
  • Imipenem
  • Cilastatin, Imipenem Drug Combination